COMMERCIAL DETAILS Sample Clauses

COMMERCIAL DETAILS. Tax exemptions. By statute the City of Fort Xxxxxxx is exempt from state and local taxes. Our Exemption Number is 11. NONWAIVER. Page 2 of 2 98-04502. Federal Excise Tax Exemption Certificate of Registry 00-0000000 is registered with the Collector of Internal Revenue, Denver, Colorado (Ref. Colorado Revised Statutes 1973, Chapter 39-26, 114 (a). Goods Rejected. GOODS REJECTED due to failure to meet specifications, either when shipped or due to defects of damage in transit, may be returned to you for credit and are not to be replaced except upon receipt of written instructions from the City of Fort Xxxxxxx.
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
COMMERCIAL DETAILS. 1. Our Details Name and ABN Advanced Human Imaging Limited ABN 85 602 111 115 (we, us, our) Office Address Xxxx 0, 00-00 Xxxxx Xxxxx Xxxxxxxxx, South Perth WA 6151 Australia 2. Client Details Name and Business / Company Number Inter-Psy B.V, Chamber of Commerce: 50074105 (you, your) Office Address Xxxx. Xxxxxxxxxxxxx 0, 0000 XX Xxxxxxxxx, XXXXXXXXXXX
Sample 1
COMMERCIAL DETAILS. A. HIRER DETAILS Hirer name & address ("the Hirer") Name of Hirer: Address: Contact person: Telephone: Email:
Sample 1
COMMERCIAL DETAILS. In this Agreement, the following words shall have the following meanings, unless the context otherwise requires: Completion Date [INSERT] Escrow Agent [INSERT] University Representative [INSERT THE NAME OF THE UNIVERSITY’S AUTHORISED REPRESENTATIVE] and any other person that University Representative nominates by giving notice in writing to the 1 Supplier Liquidated Damages (where applicable) [INSERT AMOUNT] Liquidated Damages Period (where applicable) Initial Term [INSERT] Site(s) [INSERT] Start Date [INSERT THE DATE THAT THE SYSTEM/SERVICES WILL START TO BE PROVIDED. ALTERNATIVELY IF THERE IS NO START DATE DETERMINED AT THE DATE OF SIGNATURE INSERT “THE DATE ON WHICH THE SUPPLIER COMMENCES DELIVERY OF THE SYSTEM OR PROVISION OF THE SERVICES, SUCH DATE TO BE AGREED BETWEEN THE PARTIES” OR IF THE SYSTEM/SERVICES PROVISION WILL START ON THE DATE OF SIGNATURE INSERT “THE EFFECTIVE DATE”]
Sample 1
COMMERCIAL DETAILS. Approved Currencies: Sterling Base Funding Limit: (Until replaced by specific Funding Limits) 10% of Outstanding Notified Debts Concentration Percentage: 60% of all Outstanding Notified Debts Debt Turn Target: 65 days Funding Period: UK Debts: 90 days from end of month of invoice Law: English law governs this Agreement Minimum Period: 12 months starting on the Commencement Date Monthly Returns Due Date: 15th day of each month Notice Period: 6 months Prepayment Percentage: UK Debts: 50% Prepayment Review Level: £3,000,000
Sample 1
COMMERCIAL DETAILS. 1. Our Details Name and ABN Advanced Human Imaging Limited ABN 85 602 111 115 (we, us, our) Office Address Xxxx 0, 00-00 Xxxxx Xxxxx Xxxxxxxxx, South Perth WA 6151 Australia 2. Client Details Name and Business / Company Number FITTRACK INCORPORATED, Corporation Number 1117132-1 ; FitTrack LLC, a Delaware company 7252549; FitTrack France SAS, a French company; and FitTrack UK Ltd., a United Kingdom company 12971836 (jointly and each severally, you, your) Xxxxxx Xxxxxxx 000 Xxxxx Xx Xxxx, Xxxxxxx, Xxxxxxx X0X 0X0
Sample 1

Related to COMMERCIAL DETAILS

  • Commercial Supply Celgene shall Manufacture and supply all Commercial Supplies.

  • Commercial Driver’s License As a result of recent Federal statutory requirements, the State of Michigan enacted Act 346 of 1988. The parties agree that as a result of these statutory requirements some employees within the Technical Bargaining Unit may be required to obtain and retain a Commercial Drivers License (CDL) to continue to perform certain duties for the State. Whenever a CDL is referred to in this Section, it is understood to mean the CDL and any required endorsements. In order to implement this provision, the parties agree to the following:

  • TECHNICAL EVALUATION (a) Detailed technical evaluation shall be carried out by Purchase Committee pursuant to conditions in the tender document to determine the substantial responsiveness of each tender. For this clause, the substantially responsive bid is one that conforms to all the eligibility and terms and condition of the tender without any material deviation. The Institute’s determination of bid’s responsiveness is to be based on the contents of the bid itself without recourse to extrinsic evidence. The Institute shall evaluate the technical bids also to determine whether they are complete, whether required sureties have been furnished, whether the documents have been properly signed and whether the bids are in order.

  • Commercial Crime Insurance This policy is required only if Contractor handles or has regular access to a JBE’s funds or property of significant value to the JBE. This policy must cover dishonest acts including loss due to theft of money, securities, and property; forgery, and alteration of documents; and fraudulent transfer of money, securities, and property. The minimum liability limit must be $500,000.00. To the extent that Contractor utilizes subcontractors, all subcontractors shall comply with and perform in accordance with the provisions of this Section 3 (Insurance).

  • Project Number The project number has been assigned by the Commission as the unique identifier for your project, and it cannot be changed. The project number should appear on each page of the grant agreement preparation documents to prevent errors during its handling.

  • Tests and Preclinical and Clinical Trials The preclinical studies and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company, that are described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, as applicable, and are intended to be submitted to FDA or other comparable government entities, were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Authorizations and Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder and for studies submitted to regulatory authorities for approval, current Good Clinical Practices and Good Laboratory Practices and any applicable rules and regulations of the jurisdiction in which such trials and studies are being conducted; the descriptions of the results of such studies and trials contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate and complete in all material respects and fairly present the data derived from such studies and trials; except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company is not aware of any studies or trials, the results of which the Company believes reasonably call into question the study or trial results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical stage of development; and, except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company has not received any written notices or written correspondence from the FDA or any governmental entity requiring the termination or suspension of any preclinical studies or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.

  • Project Name Register ASIC

  • Customs Cooperation 1. The Parties shall develop customs cooperation to ensure that the provisions on trade are observed. For this purpose they shall establish a dialogue on customs matters.

  • Commercial Activities Neither Contractor nor its employees shall establish any commercial activity or issue concessions or permits of any kind to Third Parties for establishing commercial activities on the Site or any other lands owned or controlled by Owner.

  • Commercial Diligence Upon execution of this Agreement, Licensee shall diligently proceed with Commercially Diligent Efforts to develop, manufacture, practice, sell and use the Licensed Products in order to make them readily available to the general public as soon as possible on commercially reasonable terms. Licensee shall continue active, diligent Commercially Diligent Efforts for one or more Licensed Product(s) throughout the term of this Agreement (“Actively Commercializing”). In addition, Licensee shall perform at least the following obligations as part of its due diligence activities hereunder:

Time is Money Join Law Insider Premium to draft better contracts faster.